Erfle V, Hehlmann R, Mellert W, Goebel F D, Rasokat H, Lechler E, Hellstern P, Köhler M, Seifried E, Heimpel H
Blut. 1985 Oct;51(4):243-9. doi: 10.1007/BF00320518.
The prevalence of antibodies to human T-lymphotropic virus III (HTLV-III) was determined in a total of 140 hemophiliacs and 36 polytransfused patients from three medical centers by an enzyme linked immunosorbent assay (ELISA) and confirmatory tests. 58 hemophiliacs (41.4%) were seropositive. In all instances where the origin of the coagulation factors given to these patients could be determined, blood products came from the United States. In addition, 2 of 36 polytransfused patients, mostly with acute leukemias, who were transfused with blood products from local donors were positive for HTLV-III antibodies. No HTLV-III antibodies were detected in 237 blood donors selected in part from the donor pool of the polytransfused patients.
通过酶联免疫吸附测定法（ELISA）和确证试验，对来自三个医疗中心的140名血友病患者和36名多次输血患者进行了人类嗜T淋巴细胞病毒III型（HTLV-III）抗体的流行率测定。58名血友病患者（41.4%）血清呈阳性。在所有能够确定给予这些患者的凝血因子来源的情况下，血液制品均来自美国。此外，36名多次输血患者中有2名主要患有急性白血病，他们接受了来自当地献血者的血液制品，其HTLV-III抗体呈阳性。在部分从多次输血患者的献血者库中挑选出的237名献血者中未检测到HTLV-III抗体。
